ArticleWorld journal of diabetes2017

Autologous bone marrow derived stem cell therapy in patients with type 2 diabetes mellitus - defining adequate administration methods.

Vikas Sood et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.